Mallinckrodt (MNK): Cutting PT to $89 On Dilutive Divestiture - Mizuho

September 29, 2016 6:20 AM EDT
Get Alerts MNK Hot Sheet
Price: $53.61 +0.96%

Rating Summary:
    17 Buy, 4 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade MNK Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Mizuho Securities analyst, Irina Koffler, reiterated her Buy rating on shares of Mallinckrodt plc (NYSE: MNK) and cut her price target to $89 from $91 after new management commentary at an investor conference indicated higher dilution associated with the sale of the nuclear imaging business. The analyst also researched the Acthar competitive risk, and concluded that the threat is relatively modest, and should not overhang the stock.

Management guided to higher dilution associated with the nuclear imaging divestiture. The analyst updated her model to incorporate a dilutive impact of $0.25-$0.35/quarter and a slightly lowered our outlook on the opioid business after additional insights into competitive dynamics emerging at an ENDP analyst event.

For an analyst ratings summary and ratings history on Mallinckrodt plc click here. For more ratings news on Mallinckrodt plc click here.

Shares of Mallinckrodt plc closed at $72.47 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst EPS Change

Related Entities

Irina Koffler

Add Your Comment